Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialJonathan E. Rosenberg, Robert Dreicer, Ani Sarkis Balmanoukian et al.|The Lancet|2016Cited by 3.7k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trialArjun Vasant Balar, Dean F. Bajorin, Matthew D. Galsky et al.|The Lancet|2016Cited by 2.2k
Therapy for metastatic melanoma: the past, present, and futureLaura Finn, Richard W. Joseph|BMC Medicine|2012Cited by 215
The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective StudyAlexandra W. Elias, Sanjay P. Bagaria, Pashtoon Murtaza Kasi et al.|Frontiers in Oncology|2017Cited by 68